510(k) device
MicroMatrix
Acell, Inc. · Wound Dressing With Animal-Derived Material(S) (KGN, Unclassified) · First FDA decision Mar 14, 2016, newest Oct 6, 2017BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
6
Naming "MicroMatrix"
MAUDE reports
38
Brand "MicroMatrix", since 2015
PubMed studies
57
Mentioning "MicroMatrix"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MicroMatrix
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- MicroMatrix510(k)
K172399 · Decided Oct 6, 2017 · 59 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
- MicroMatrix510(k)
K153754 · Decided Mar 14, 2016 · 76 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MicroMatrix", any status and sponsor, newest update first.
- The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®Recruiting
Benjamin T. MillerAcademic, hospital or other
NCT06857708 · 50 participants (planned) · Start Mar 5, 2025 · Primary completion Sep 1, 2028
Device: Cytal® Wound Matrix; MicroMatrix® · For: Necrotizing Fascitis; Necrotizing Soft Tissue Infection
Sites: Cleveland, Ohio
Integra LifeSciences CorporationPublic (IART)
NCT06629506 · 25 participants · Start Dec 12, 2024 · Primary completion Aug 31, 2025
Device: MicroMatrix® Flex; MicroMatrix® UBM Particulate and 1 more · For: Pressure Injury; Venous Ulcer; Necrotizing Soft Tissue Infection and 2 more
Sites: Aurora, Colorado; Washington D.C., District of Columbia; Lake Success, New York
Integra LifeSciences CorporationPublic (IART)
NCT03632954 · 37 participants · Start Dec 11, 2018 · Primary completion Jan 27, 2020
Device: ACell Arm · For: Wounds
Sites: Long Island City, New York
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MicroMatrix", and for the whole product code for context.
This brand
38 reports: 3 malfunction, 35 injury, 0 death
Whole product code KGN
154 reports: 32 malfunction, 117 injury, 1 death
Newest reports for this brand
- MICROMATRIX FLEX 5CCInjury
3005920706-2025-00014 · Received May 28, 2025 · Event dated Apr 9, 2025
Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Impaired Healing
- UNKNOWN MICROMATRIXInjury
3005920706-2025-00002 · Received Feb 12, 2025
Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Unspecified Infection
- MICROMATRIX, 500 MGMalfunction
3005920706-2024-00008 · Received Oct 4, 2024 · Event dated Sep 6, 2024
Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
Device problem as coded: Contamination of Device Ingredient or Reagent
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "MicroMatrix"[tiab]. The summary above synthesizes these.
- Novel use of porcine urinary bladder matrix for pediatric pilonidal wound care: preliminary experience.
Dorman RM, Bass KD · Pediatr Surg Int · 2016
- Nanostructured Scaffold, Combined with Human Dental Pulp Stem Cell Secretome, Induces Vascularization in Medicinal Leech Model.
Marcolli G, Baranzini N, Barone L, et al. · Micromachines (Basel) · 2025
- Micromatrix. Computer lib.
Grunder TM · Health Matrix · 1984Comparative Study
- Micromatrix. Apple II.
Littenberg B · Health Matrix · 1983
- Towards the development of automated fed-batch cell culture processes at microscale.
Wiegmann V, Giaka M, Martinez CB, et al. · Biotechniques · 2019Research Support, Non-U.S. Gov't
- Microbioreactor (micro-Matrix) potential in aerobic and anaerobic conditions with different industrially relevant microbial strains.
D'ambrosio S, Ventrone M, Alfano A, et al. · Biotechnol Prog · 2021Research Support, Non-U.S. Gov't, Review
- Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction.
Zhao S, Xu Z, Wang H, et al. · Nat Commun · 2016Research Support, N.I.H., Extramural
- Cultivation of microbial cultures at high cell density in microbioreactor fermentations to increase protein yield.
Pepeliaev S, Ehebauer MT · Biotechnol Appl Biochem · 2023
- Pediatric Reconstruction of Full-Thickness Dog Bite Scalp Avulsion with a Combination of Acellular and Matrix Products: A Case Report.
Grussu F, Ciprandi G, Lo Torto F, et al. · Medicina (Kaunas) · 2024Case Reports
- Methods to mitigate Escherichia coli blooms in human ex vivo colon model experiments using the high throughput micro-Matrix bioreactor fermentation system.
Mathur H, Mechoud MA, Matthews C, et al. · MethodsX · 2023
- Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
Roine J, Kaasalainen M, Peurla M, et al. · Mol Pharm · 2015Research Support, Non-U.S. Gov't
- Infant Fecal Fermentations with Galacto-Oligosaccharides and 2'-Fucosyllactose Show Differential Bifidobacterium longum Stimulation at Subspecies Level.
Lindner C, Looijesteijn E, Dijck HV, et al. · Children (Basel) · 2023
Other devices of this type
Also filed under product code KGN.
- Cytal® Wound MatrixAcell, Inc. · 510(k) 2024
- PriMatrix Dermal Repair ScaffoldTei Biosciences, Inc. · 510(k) 2016
- Marigen Wound ExtraKerecis Limited · 510(k) 2025
- MatriDermMedskin Solutions Dr. Suwelack AG · 510(k) 2026
- CollOvine Wound PowderOvigenex, LLC · 510(k) 2026
- SurgiAid Collagen Wound Dressing (HA)Maxigen Biotech, Inc. · 510(k) 2025
- Collagen Wound DressingWinner Medical Co., Ltd. · 510(k) 2025
- Corplex P/ Theracor P/ Allacor PStimlabs, LLC · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.